UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer

Breast cancer research and treatment, 2020-04, Vol.180 (2), p.331-341

2020

Volltextzugriff (PDF)

Assessment of a cancer genomic profile test for patients with metastatic breast cancer

Scientific reports, 2022-03, Vol.12 (1), p.4813-4813, Article 4813

2022

Volltextzugriff (PDF)

A Series of PIN/Password Input Methods Resilient to Shoulder Hacking Based on Cognitive Difficulty of Tracing Multiple Key Movements

IEICE Transactions on Information and Systems, 2020/07/01, Vol.E103.D(7), pp.1623-1632

2020

Volltextzugriff (PDF)

Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial

Breast cancer research and treatment, 2021-08, Vol.188 (3), p.675-683

2021

Volltextzugriff (PDF)

Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab -paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031)

Japanese journal of clinical oncology, 2022-10, Vol.52 (10), p.1124-1133

2022

Volltextzugriff (PDF)

Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial

Japanese journal of clinical oncology, 2023-01, Vol.53 (1), p.4-15

2023

Volltextzugriff (PDF)

Impact of Primary Pegfilgrastim Prophylaxis on Relative Dose Intensity in Neoadjuvant/Adjuvant FEC-100 Chemotherapy

Anticancer research, 2020-02, Vol.40 (2), p.915-921

2020

Volltextzugriff (PDF)

Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.7932-7940

2023

Volltextzugriff (PDF)

Evaluation of trastuzumab without chemotherapy as a postoperative adjuvant therapy in HER2-positive elderly breast cancer patients: Randomized controlled trial (RESPECT)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.510-510

2018

Volltextzugriff (PDF)

Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review

Case reports in oncology, 2017-07, Vol.10 (2), p.605-612

2017

Volltextzugriff (PDF)

A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy

Case reports in oncology, 2017-07, Vol.10 (2), p.620-626

2017

Volltextzugriff (PDF)

Oxidative DNA damage: Induction by fructose, in vitro, and its enhancement by hydrogen peroxide

Mutation research. Genetic toxicology and environmental mutagenesis, 2024-01, Vol.893, p.503719-503719, Article 503719

2024

Volltextzugriff (PDF)

Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-15-02

2022

Volltextzugriff (PDF)

Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer

Radiology, 2018-01, Vol.286 (1), p.49-57

2018

Volltextzugriff (PDF)

EPIK-B6: A phase 2, open-label, 2-part, multicenter study of alpelisib in combination with fulvestrant for men and postmenopausal women with PIK3CA mutation HR–positive, HER2-negative, advanced breast cancer, which progressed on/after aromatase inhibitor treatment in Japan

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS1117-TPS1117

2023

Volltextzugriff (PDF)

Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)

Breast cancer research and treatment, 2023-06, Vol.199 (2), p.253-263

2023

Volltextzugriff (PDF)

MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer

Annals of oncology, 2021-07, Vol.32, p.S320-S320

2021

Volltextzugriff (PDF)

MO3-8-2Characteristics and prognosis of leptomeningeal metastasis in patients with breast cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_6)

2019

Volltextzugriff (PDF)

Characteristics and prognosis of leptomeningeal metastasis in patients with breast cancer

Annals of oncology, 2019-10, Vol.30, p.vi113

2019

Volltextzugriff (PDF)

Abstract OT2-02-07: Fulvestrant with additional palbociclib in advanced or metastatic hormone receptor-positive HER2-negative breast cancer after progression to fulvestrant monotherapy: JBCRG- M07 (FUTURE trial)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.OT2-02-07-OT2-02-07

2020

Volltextzugriff (PDF)

Abstract P5-01-15: Monitoring of CDK4/6 inhibitor treatment response through blood liquid biopsy in metastatic breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-01-15

2020

Volltextzugriff (PDF)

Differences of TILs, hormone receptor, and HER2 status between primary and metastatic tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1075-1075

2018

Volltextzugriff (PDF)

MO1-12-1Clinical introduction of Microsatellite instability (MSI) test for the Solid Tumors at a single institute

Annals of oncology, 2019-10, Vol.30 (Supplement_6)

2019

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

ThemaBreast Neoplasms - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer

Assessment of a cancer genomic profile test for patients with metastatic breast cancer

A Series of PIN/Password Input Methods Resilient to Shoulder Hacking Based on Cognitive Difficulty of Tracing Multiple Key Movements

Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial

Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab -paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031)

Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial

Impact of Primary Pegfilgrastim Prophylaxis on Relative Dose Intensity in Neoadjuvant/Adjuvant FEC-100 Chemotherapy

Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study

Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice

Evaluation of trastuzumab without chemotherapy as a postoperative adjuvant therapy in HER2-positive elderly breast cancer patients: Randomized controlled trial (RESPECT)

Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review

A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy

Oxidative DNA damage: Induction by fructose, in vitro, and its enhancement by hydrogen peroxide

Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial)

Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV

Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer

EPIK-B6: A phase 2, open-label, 2-part, multicenter study of alpelisib in combination with fulvestrant for men and postmenopausal women with PIK3CA mutation HR–positive, HER2-negative, advanced breast cancer, which progressed on/after aromatase inhibitor treatment in Japan

Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)

MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer

MO3-8-2Characteristics and prognosis of leptomeningeal metastasis in patients with breast cancer

Characteristics and prognosis of leptomeningeal metastasis in patients with breast cancer

Abstract OT2-02-07: Fulvestrant with additional palbociclib in advanced or metastatic hormone receptor-positive HER2-negative breast cancer after progression to fulvestrant monotherapy: JBCRG- M07 (FUTURE trial)

Abstract P5-01-15: Monitoring of CDK4/6 inhibitor treatment response through blood liquid biopsy in metastatic breast cancer

Differences of TILs, hormone receptor, and HER2 status between primary and metastatic tumors

MO1-12-1Clinical introduction of Microsatellite instability (MSI) test for the Solid Tumors at a single institute

Aktive Filter

Suchergebnisse filtern